BTFV

BTFV (Brain Too Free Ventures) is a Singapore-based early-stage venture firm with a public posture that emphasizes founder-friendly, conviction-led investing. Their thesis is broadly across consumer, software, and emerging technology in Southeast Asia and adjacent geographies. Healthcare-specific exposure is not the headline of the fund’s positioning, though they may participate in digital health and health-tech rounds where the business is software-led and the SEA market opportunity is clear. For healthcare AI founders, BTFV is most credible as a SEA seed co-investor: plausible check sizes of $100K to $500K, deployed alongside a primary-led round, with value-add tilted toward founder coaching and SEA network rather than clinical or regulatory specialization. Stage focus is seed and pre-seed. Founders who should approach: Southeast Asian healthcare AI startups with a software-shaped business model, founders looking for an early conviction check that brings local network access, and teams who value founder-to-founder support over institutional brand. Founders who should not approach: regulated medical devices, biotech, US-only digital health, and teams that need a domain-specialist healthcare lead — BTFV cannot credibly anchor that journey. Entry path is warm introduction through SEA founders, the Singapore startup ecosystem (NUS Enterprise, BLOCK71, Antler alumni), or co-investors in the regional seed network. Their LinkedIn page is the most reliable contact point. Cold outbound is feasible given their accessible posture but should still be paired with a thoughtful note that demonstrates fit. Be prepared to discuss SEA-specific go-to-market, country-by-country regulatory awareness, and the local team you have or are building.